NCT02216357View on ClinicalTrials.gov

Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Aspirin Exacerbated Respiratory Disease (AERD)
Interventions
DRUG

Ifetroban, Oral Capsule

DRUG

Placebo, Oral Capsule

Trial Locations (3)

10994

Allergy & Asthma Consultants of Rockland & Bergen, West Nyack

32130

Scripps Clinic, San Diego

66210

Kansas City Allergy and Asthma Associates, PA., Overland Park

Sponsors
All Listed Sponsors
lead

Cumberland Pharmaceuticals

INDUSTRY